文献速递肺外科

对cT1a-c期肺癌行肺段切除术后因脏层胸膜侵犯上调为pT2a期:是否需要补行肺叶切除?

Upstaged from cT1a-c to pT2a lung cancer, related to visceral pleural invasion patients, after segmentectomy: is it an indication to complete resection to lobectomy?
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2023-01-01

这项多中心回顾性研究分析了2007年4月至2019年12月间因cT1a-cN0非小细胞肺癌行肺段或肺叶切除、术后因脏层胸膜侵犯上调为pT2a期的患者,比较两种术式的预后。肺叶切除191例(75.4%),肺段切除62例(24.5%)。肺段切除组远处复发率较高(P=0.027),但5年无病生存率和总生存率无显著差异,倾向性评分匹配后结论一致。作者认为发现脏层胸膜侵犯似乎不是补行肺叶切除的指征。

要点

  • 肺段切除组远处复发率高于肺叶切除组(P=0.027)。
  • 两组5年无病生存率(70% vs 64.7%)和总生存率(73% vs 75.8%)无显著差异。
  • 作者认为脏层胸膜侵犯上调为pT2a似乎不是补行肺叶切除的指征。

核心结论

  • 对因cT1a-c期非小细胞肺癌行肺段切除、术后因脏层胸膜侵犯上调为pT2a期的患者,发现脏层胸膜侵犯似乎不是将切除范围扩大至肺叶切除的指征。

研究设计与样本

  • 多中心回顾性研究,纳入2007年4月至2019年12月间3个中心收治的患者。
  • 肺叶切除191例(75.4%),肺段切除62例(24.5%)。
  • 采用Kaplan-Meier法和Cox回归分析评估生存与复发。

主要发现

  • 肺叶切除组与肺段切除组5年无病生存率分别为70%和64.7%,无差异。
  • 两组局部区域复发和同侧胸膜复发均无差异,肺段切除组远处复发率较高(P=0.027)。
  • 肺叶切除组与肺段切除组5年总生存率分别为73%和75.8%,相似。
  • 倾向性评分匹配后,两组5年无病生存率(肺叶切除85% vs 肺段切除66.9%,P=0.27)和5年总生存率(肺叶切除76.3% vs 肺段切除80.1%,P=0.42)均无差异。
  • 肺段切除对复发和生存均无影响。

临床怎么用

  • 作者认为,肺段切除术后发现脏层胸膜侵犯(pT2a上调)似乎不是将切除范围扩大至肺叶切除的指征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Segmentectomy may be indicated for T1a-cN0 non-small-cell lung cancer. However, several patients are upstaged pT2a at final pathological examination due to visceral pleural invasion (VPI). As resection is usually not completed to lobectomy, this may raise issue of potential worse prognosis. The aim of this study is to compare prognosis of VPI upstaged cT1N0 patients operated on by segmentectomy or lobectomy. METHODS: Data of patients from 3 centres were analysed. This was a retrospective study, of patients operated on from April 2007 to December 2019. Survival and recurrence were assessed by Kaplan-Meier method and cox regression analysis. RESULTS: Lobectomy and segmentectomy were performed in 191 (75.4%) and in 62 (24.5%) patients, respectively. No difference in 5-year disease-free survival rate between lobectomy (70%) and segmentectomy (64.7%) was observed. There was no difference in loco-regional recurrence, nor in ipsilateral pleural recurrence. The distant recurrence rate was higher (P = 0.027) in the segmentectomy group. Five-year overall survival rate was similar for both lobectomy (73%) and segmentectomy (75.8%) groups. After propensity score matching, there was no difference in 5-year disease-free survival rate (P = 0.27) between lobectomy (85%) and segmentectomy (66.9%), and in 5-year overall survival rate (P = 0.42) between the 2 groups (lobectomy 76.3% vs segmentectomy 80.1%). Segmentectomy was not impacting neither recurrence, nor survival. CONCLUSIONS: Detection of VPI (pT2a upstage) in patients who underwent segmentectomy for cT1a-c non-small-cell lung cancer does not seem to be an indication to extend resection to lobectomy.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lula Lukadi J, Mariolo AV, Ozgur EG, et al. Upstaged from cT1a-c to pT2a lung cancer, related to visceral pleural invasion patients, after segmentectomy: is it an indication to complete resection to lobectomy? Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37294828. doi:10.1093/icvts/ivad102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。